Repligen RGEN
NASDAQ RGEN
$177.23 -15.00 (-7.80%)
At close: Oct 1, 2026 · 4:00 PM EDT

Repligen (RGEN) Restructuring Costs (2025 - 2026)

Updated

Repligen's Restructuring Costs came in at $2.72 million for Q2 2026, up 25.7% from $2.16 million a year earlier and up 81.7% from the prior quarter.

Analysis

Repligen (RGEN) Restructuring Costs (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Repligen reported Restructuring Costs of $8.35 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Repligen 10.85 Bn 7.74 Bn 110.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.72 Mn
Mar 31, 2026 1.50 Mn
Jun 30, 2025 2.16 Mn
Mar 31, 2025 1.97 Mn
API Access

Repligen Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=RGEN&period=max&api_key=YOUR_API_KEY